BGLC: BioNexus Gene Lab Corp. Stock

SIC 8071 – Medical Laboratories

Valuation
Market Cap ($M) 10.60
Enterprise Value ($M) 7.99
Book Value ($M) 9.66
Book Value / Share 0.55
Price / Book 1.10
NCAV ($M) 6.30
NCAV / Share 0.36
Price / NCAV 1.68

Profitability (mra)
Return on Invested Capital (ROIC) -0.27
Return on Assets (ROA) -0.32
Return on Equity (ROE) -0.40

Liquidity (mrq)
Quick Ratio 4.24
Current Ratio 4.93

Balance Sheet (mrq) ($M)
Current Assets 8.05
Assets 11.40
Liabilities 1.74
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 9.77
Operating Income -2.04
Net Income -2.63
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -1.30
Cash from Investing -0.38
Cash from Financing 5.75

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
01-23 13G Erayak Power Solution Group Inc. 18.18
01-17 13D Lai Soo Kow 7.03 0.00
10-17 13G Wong Chan Chong 7.03

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2023 ☐ TRANSITION REPORT UNDER SECTION
2024-03-26 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A
2023-11-20 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-16 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-30 20,884 70,705 29.54
2024-04-29 10,367 5,129 202.13
2024-04-26 10,184 5,678 179.36
2024-04-25 13,633 7,492 181.97

(click for more detail)

Similar Companies
CELC – Celcuity Inc. DMTK – DermTech, Inc.


Financial data and stock pages provided by
Fintel.io